Lieff Cabraser Attorneys Featured at BASF Antitrust for HR Seminar

Lieff Cabraser Attorneys Featured at BASF Antitrust for HR Seminar

Lieff Cabraser attorneys Lin Y. Chan and Dean M. Harvey will be speaking at the Bar Association of San Francisco’s Antitrust for HR: No-Poach and Wage Fixing Agreements seminar on November 9, 2017. Ms. Chan will be moderating the panel, and Mr. Harvey will participate in the discussion. [Read more…]

Dean Harvey in the Durham News Observer on the Duke/UNC No-Hire Lawsuit

Duke/UNC No-Hire Agreement Lawsuit

Lieff Cabraser represents Duke University School of Medicine instructor Danielle M. Seaman, M.D., in a class action lawsuit against Duke, UNC Med School, and other entities charging that the defendants entered into an express, secret agreement not to hire certain medical facility faculty and staff that they each employed, reducing or eliminating competition for skilled medical labor. The parties recently announced a preliminary settlement with UNC Med School, leaving the action to continue with respect to Duke University School of Medicine. [Read more…]

UNC School of Medicine Agrees to Ban No-Hire Arrangements to Settle Antitrust Lawsuit

Duke 'No-Hire' Case

Lieff Cabraser represents Duke University School of Medicine instructor Danielle M. Seaman, M.D., in a class action lawsuit against Duke, UNC Med School, and other entities charging that the defendants entered into an express, secret agreement not to hire or attempt to hire certain medical facility faculty and staff that they each employed, reducing or eliminating competition for skilled medical labor. The lawsuit seeks to recover damages and obtain injunctive relief, including treble damages, for defendants’ alleged violations of federal and North Carolina antitrust law. [Read more…]

Law360 Rising Star Profile: Lieff Cabraser’s Lin Chan

Law360 Rising Star Profile: Lieff Cabraser’s Lin Chan

Law360 has published an in-depth profile of Lieff Cabraser partner Lin Y. Chan, named a Law360 Rising Star for 2017 for Competition. The profile highlights Ms. Chan’s biggest case to date (illegal non-compete agreements over the blockbuster antibiotic Cipro), where she gets her motivation, how she became a competition and antitrust attorney, and the advice she would give to young attorneys striving to be successful in the law. [Read more…]

Lieff Cabraser Named to Leadership Position in Generic Drugs Pricing Antitrust Litigation

Lieff Cabraser Named to Leadership Position in Generic Drugs Pricing Antitrust Litigation

Beginning in February 2015, Lieff Cabraser conducted an extensive investigation into dramatic price increases of certain generic drugs. Lieff Cabraser worked alongside economists and industry experts and interviewed industry participants to evaluate possible misconduct. In December of 2016, Lieff Cabraser, with co-counsel, filed the first case alleging price-fixing of levothyroxine, the primary treatment for hypothyroidism, among the most widely prescribed drugs in the world. [Read more…]

Noncompete Clauses Keep Workers Locked In

Noncompete Clauses Keep Workers Locked In

The use of noncompete clauses in employment contracts has grown enormously. Designed to prevent employees from leaving for a competitor, noncompete agreements also work to bind employees to one company, ultimately making it more difficult for them to get ahead. As noted by the New York Times, this reflects “a broad shift in which companies assert ownership over work experience as well as work,” and the paper further notes that employment lawyers see noncompete agreement usage “exploding.” [Read more…]

Final Approval Granted to $225 Million Barr Labs Settlement in Cipro Antitrust Litigation

Final Approval Granted to $225 Million Barr Labs Settlement in Cipro Antitrust Litigation

On April 21, 2017, Judge Ronald L. Styn of the Superior Court of California granted final approval to a $225 million settlement with Barr Laboratories in the Cipro Antitrust litigation. Lieff Cabraser and co-counsel represent California consumers and third party payors in the class action lawsuit charging that Bayer Corporation, Barr Laboratories, and the HMR Defendants colluded to block consumer access to affordable, generic versions of Cipro through a massive $398.1 million payment by Bayer to Barr and other generic drug makers. [Read more…]

Carolinas HealthCare Anti-Competition Lawsuit Allowed to Proceed

Carolinas HealthCare Anti-Competition Lawsuit Allowed to Proceed

As reported by The Charlotte Observer, North Carolina Business Court Judge Michael Robinson has denied the Carolinas HealthCare System’s motion to dismiss a lawsuit accusing the hospital giant of driving up health care costs through illegal efforts to prevent competition. The lawsuit, filed by Lieff Cabraser and co-counsel in September of 2016, accuses CHS of placing improper contract restrictions on insurers forbidding them from guiding customers to lower-cost competing hospitals. [Read more…]

New Measure That Will Reshape Class Action Lawsuits Under Senate Review

New Measure That Will Reshape Class Action Lawsuits Under Senate Review

A new bill seeking to curb enforcement of U.S. class action lawsuits is facing opposition from antitrust groups, including the Committee to Support the Antitrust Laws (COSAL). The measure, H.R. 985 – Fairness in Class Action Litigation and Furthering Asbestos Claim Transparency Act of 2017, is currently under review by the Senate Judiciary Committee after being passed by the House on a 220-201 vote March 9. The bill would add preconditions for class actions and complex litigation cases. [Read more…]